Evaluation of the safety and topical efficacy of a scar gel after 90 days of continuous use, comparing it to a benchmark for preventing hypertrophic scars and improving appearance, hydration and pigmentation.
Participants of both sexes aged between 18 and 70 years;
Participants with recent scars (<30 days);
Participants with phototypes III to VI according to the Fitzpatrick scale;
Agree to follow the trial procedures and attend the center on the days and times determined for evaluations;
Pregnancy or risk of pregnancy;
History of atopic or allergic reactions to cosmetic products;
Participants who are using topical antibiotics or other skin products on the same area being evaluated;
Immunosuppression due to drugs or active diseases;
Parallel
Scar gel
DeviceHealth care product (scar gel)
Scar gel comparator
DeviceHealth care product (Scar gel comparator)
Assessment of clinical and perceived efficacy
Evaluate the prevention of hypertrophic scars after 90 days of continuous use of the investigational product. The dermatologist will perform assessments of the clinical parameters using the POSAS scale.
Perceived efficacy
To compare the treatments of the benchmark product versus the investigational product in improving the appearance of scars, discomfort, skin hydration, itching and normalization of scar pigmentation, after 90 days of use, through a questionnaire on perceived efficacy.
Click on the lead sponsor to view all of their trials.
